Synopsis
Stay uptodate with the latest in heart failure, cardiac hemodynamics, pulmonary hypertension and cardiac transplantation.
Episodes
-
#27 AHA 2020 Trials
15/02/2021 Duration: 01h47minWe discuss several of the important data coming out the American Heart Association 2020 meeting. Thanks for listening. Please like, subscribe and give us a rating.
-
#26 Cardiorenal Protection with Newer Antidiabetic Agents
09/01/2021 Duration: 01h23minWe have a multispecialty panel discussion on the cardiorenal benefits of newer antidiabetic agents with Drs Rangaswami, Vaduganathan, Tuttle and Bhalla. Thanks for listening. Please like, subscribe and give us a rating.
-
#25 ESC 2020 Trials
21/12/2020 Duration: 01h34minWe discuss several of the important data coming out the European Society of Cardiology 2020 meeting. Thanks for listening. Please like, subscribe and give us a rating.
-
#24 Cardiogenic Shock Case Discussion
27/09/2020 Duration: 46minWe discuss cardiogenic shock and decision making in the case of a young female presenting to the ER. We have a panel of cardiologists guide the discussion. Drs Rene Alvarez, Daniel Sims and Alec Vishnevski discuss the case presented by cardiology fellow Rachna Kataria, MD. Thanks for listening. Please like, subscribe and give us a rating.
-
#23 Understanding Cardiogenic Shock with Navin Kapur MD
19/08/2020 Duration: 54minWe discuss the various aspects of cardiogenic shock including definition, heterogeneity, classification and management with an internationally renowned expert in the field Dr Navin Kapur. Dr Kapur is the Director of the Acute Mechanical Circulatory Support Program at Tufts University School of Medicine, Boston, MA. Listen, like, subscribe, and give us a high rating.
-
#22 Cardio-Oncology from the Cardiologist- Cardiotoxicity with Sherry-Ann Brown MD PhD
03/08/2020 Duration: 01h02minWe discuss several aspects of cardio-oncology including screening protocols, specific chemotherapy related cardiotoxicities and management of cardiovascular disease among cancer patients and cancer survivors. Dr Sherry-Ann Brown is the director of Cardio-Oncology at the Medical College of Wisconsin, Milwaukee, WI. Listen, like, subscribe, and give us a high rating.
-
#21 Cardio-Oncology- Arrhythmias in Cancer Patients with Michael Fradley MD and Avirup Guha MD
19/07/2020 Duration: 41minWe discuss several aspects of cardiac arrhythmias and their management among cancer patients and cancer survivors with Drs Fradley and Guha. Dr Fradley is an electrophysiologist and Dr Guha is a non-invasive cardiologist, both with tremendous expertise in cardio-oncology. Dr Fradley is the Medical Director of Cardio-Oncology at University of Pennsylvania, Philadelphia, PA. Listen, like, subscribe, and give us a high rating.
-
#20 Cardio-Oncology from the Radiation Oncologist- Radiation Therapy and Cardiovascular Disease with Brett Lewis MD PhD
15/07/2020 Duration: 40minWe discuss some radiation physics, role for ionizing radiation in treating cancer & related cardiac damage with Dr Brett Lewis MD PhD. Dr. Lewis has interest & expertise in treating several thoracic malignancies & practices at Hackensack Meridian Health, NJ. Listen, like, subscribe, and give us a high rating.
-
#19 Cardio-Oncology from the Oncologist- Cancer Therapy and Cardiovascular Toxicity with Kaushal Parikh, MD
10/06/2020 Duration: 48minWe discuss several classes of cancer therapies including chemotherapy, immunotherapy, CAR T-Cell therapies and related cardiovascular toxicity from the perspective of a board certified oncologist Dr Kaushal Parikh, MD. Dr Parikh specializes in thoracic oncology and practices at Hackensack Meridian Health, NJ. Listen, Like, Subscribe, and give us a high rating!
-
#18 ACC 2020 Trials
22/05/2020 Duration: 01h24minWe review and discuss a lot of exciting data including late-breaking trials from the American College of Cardiology Scientific Sessions in March, 2020. Listen, Like, Subscribe, and give us a high rating!
-
#17 Inpatient HFrEF & HFpEF management with Carolyn Lam MBBS PhD
14/05/2020 Duration: 43minWe review the inpatient management in HFrEF, role of GDMT initiation & HF exacerbating drugs. We end the episode with a discussion on HFpEF & device therapies with Professor Carolyn Lam, a Senior Consultant of the National Heart Centre, Singapore and Professor of Duke-NUS Cardiovascular Academic Clinical Program. Listen, Like, Subscribe, and give us a rating!
-
#16 COVID-19 Cardiovascular Update with Jennifer Haythe, MD
26/03/2020 Duration: 59minWe discuss Coronavirus Disease 2019 and cardiovascular involvement. Dr Jennifer Haythe, a Heart Failure cardiologist from Columbia University Medical Center talks about the cardiovascular sequelae associated with COVID-19 and related management. We end with HCW protection, appropriate PPE, new data of HCQ and investigational therapies. Listen, Like, Subscribe, and give us a rating!
-
#15 COVID-19 UPDATE with Udit Chaddha, MD
23/03/2020 Duration: 39minWe discuss Coronavirus Disease 2019 in the USA. Dr Udit Chaddha, a Pulmonary Disease & Critical Care specialist from the Icahn School of Medicine - Mount Sinai Hospital in New York talks about the virus, disease identification, healthcare worker protection and management of related acute respiratory illness. Listen, Like, Subscribe, and give us a rating!
-
#14 Transthyretin (ATTR) amyloidosis with Mathew Maurer, MD
15/03/2020 Duration: 01h03minWe discuss transthyretin (aTTR) cardiac amyloidosis, symptoms, appropriate diagnostic testing and different treatment options available. Dr. Mathew Maurer from NewYork-Presbyterian Hospital/Columbia University shares his expertise with us. Listen, Like, Subscribe, and give us a rating!
-
#13 Light chain amyloidosis with Ronald Witteles, MD
29/02/2020 Duration: 50minManagement of light chain or AL amyloidosis has changed with major advances in recent years. Dr. Ronald Witteles is a Stanford Cardiologist with particular expertise in the treatment of cardiac amyloidosis and shares his expertise with us. He serves as Co-Director of the Stanford Amyloid Center, one of the world's leading amyloid centers. Listen, Like, Subscribe, and give us a rating!
-
#12 Sudden Cardiac Death in Heart Failure with Nasrien Ibrahim, MD
05/02/2020 Duration: 42minSudden cardiac death in heart failure has changed as therapies have evolved. We discuss arrhythmic and non arrhythmic sudden death in heart failure, and how we can lower its incidence. Dr Nasrien Ibrahim MD from Massachusetts General Hospital affiliated with Harvard Medical School shares her expertise. Listen, Like, Subscribe, and give us a rating!
-
#11 Diabeto-Cardiology: From the Cardiologist's perspective with Muthiah Vaduganathan, MD
20/01/2020 Duration: 52minDiabetes management is evolving and we discuss the role of cardiologists in improving cardio-metabolic care. Dr Muthiah Vaduganathan MD MPH from Brigham and Women's Hospital & Harvard Medical School shares his expertise on the evidence for newer drugs and how cardiologists can get engaged in diabetes management. This is episode three of four in our Diabeto-Cardiology series. Listen, Like, Subscribe, Tweet and don't forget to give us a Rating!!
-
#10 AHA 2019 trials and Apple Heart Study
12/12/2019 Duration: 01h33minBig trials presented at AHA 2019!! We have two interviews and we discuss ISCHEMIA, ISCHEMIA CKD, COLCOT, ORION-10, BETonMACE, AVR in asymptomatic very severe AS, GALILEO, DAPA-HF, and the Apple Heart study. Listen, Like, Subscribe and don't forget to give us a Rating!!
-
#9 Diabeto-Cardiology: From the endocrinologist's perspective with Ritika Puri, MD
14/11/2019 Duration: 47minDiabetes management is changing rapidly, and with that we have newer management strategies with cardiovascular benefit. Dr Ritika Puri shares an endocrinologist's perspective on where diabetes stands today, and shares interesting insights into how to approach cardiovascular disease in diabetes management. This is episode two of four in our Diabeto-Cardiology series. Listen, Like, Subscribe and don't forget to give us a Rating!!
-
#8 Diabeto-Cardiology: Let's get to know the diabetic drugs with Ilya Danelich PharmD
31/10/2019 Duration: 32minIlya Danelich PharmD (Board Certified Cardiac Pharmacist) walks us through the mechanism of action and pearls for different classes of diabetic drugs including the NEWER drugs. We also describe how to prescribe the newer SGLT2 inhibitors and review mechanisms for adverse effects and cardiovascular/renal benefits. This is episode one of four in our Diabeto-Cardiology series. Listen, Like, Subscribe and don't forget to give us a Rating!!